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Abstract
Epidemiological research suggests that paternal obesity may increase the risk of fathering
small for gestational age offspring. Studies in non-human mammals indicate that such
associations could be mediated by DNA methylation changes in spermatozoa that influ-
ence offspring development in utero. Human obesity is associated with differential DNA
methylation in peripheral blood. It is unclear, however, whether this differential DNA meth-
ylation is reflected in spermatozoa. We profiled genome-wide DNA methylation using the
Illumina MethylationEPIC array in a cross-sectional study of matched human blood and
sperm from lean (discovery n = 47; replication n = 21) and obese (n = 22) males to analyse
tissue covariation of DNA methylation, and identify obesity-associated methylomic signa-
tures. We found that DNA methylation signatures of human blood and spermatozoa are
highly discordant, and methylation levels are correlated at only a minority of CpG sites
(~1%). At the majority of these sites, DNA methylation appears to be influenced by genetic
variation. Obesity-associated DNA methylation in blood was not generally reflected in
spermatozoa, and obesity was not associated with altered covariation patterns or acceler-
ated epigenetic ageing in the two tissues. However, one cross-tissue obesity-specific
hypermethylated site (cg19357369; chr4:2429884; P = 8.95 × 10−8; 2% DNA methylation
difference) was identified, warranting replication and further investigation. When com-
pared to a wide range of human somatic tissue samples (n = 5,917), spermatozoa dis-
played differential DNA methylation across pathways enriched in transcriptional
regulation. Overall, human sperm displays a unique DNA methylation profile that is highly
discordant to, and practically uncorrelated with, that of matched peripheral blood. We
observed that obesity was only nominally associated with differential DNA methylation in
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sperm, and therefore suggest that spermatozoal DNA methylation is an unlikely mediator
of intergenerational effects of metabolic traits.
Author summary
Research primarily conducted in mice suggests that obesity in fathers can have effects on
the health of their offspring via changes in the fathers’ sperm. It is not confirmed whether
this is true for humans. In this study, we examined sperm and blood from lean and obese
men to understand whether obesity affects DNA methylation in both tissues. DNA methyl-
ation can impact on gene function and therefore may affect offspring health. We found
that there was almost no association between obesity and DNA methylation in sperm. We
also showed that DNA methylation patterns found in the blood of obese individuals are not
present in sperm from obese men. Generally, DNA methylation patterns across the whole
genome were completely different and uncorrelated between the two tissues. Lastly, we
compared DNA methylation patterns in sperm to those in many other tissues, including
for example blood and brain samples, and found that sperm has a unique signature of
DNA methylation—one that points to genes involved in regulating overall levels of tran-
scription. We conclude that obesity probably does not affect DNA methylation in sperm
and that, although more research is needed, if obesity in fathers does influence the health of
their children, this process is unlikely to be mediated by spermatozoal DNA methylation.
Introduction
Multiple large-scale epigenome-wide association studies in humans have shown that environ-
mental and acquired phenotypes, including smoking, ageing and obesity, are associated with
altered DNA methylation in peripheral blood [1–4]. Whether such phenotypes also have the
potential to induce epigenetic changes in gametes has generated considerable interest in recent
years. Studies in non-human mammals suggest that the spermatozoal DNA methylome can be
influenced by factors such as dietary alterations, toxicants and even psychological stress [5–
10], although the majority of these results have yet to be replicated independently. A small
number of studies also suggest that acquired traits in male mice induce epigenetic changes in
sperm, which in turn influence the physiology of offspring [7, 11, 12].
There is little evidence for such inter- and transgenerational effects of acquired phenotypes
via epigenetic inheritance in humans. This is partly due to the fact that human sperm is rarely
analysed outside of a reproductive medicine setting and is less accessible than, for example,
peripheral blood. Further, it is ethically and practically impossible to perform a study of trans-
generational effects in humans in which all potential external and lifestyle-related confounders
are removed, and inter-individual genetic variation is generally not controllable. In addition,
one needs to account for the two-stage process of epigenetic reprogramming of primordial
germ cells and preimplantation embryos that occurs between generations [13]. Lastly, epige-
netic signatures are highly tissue- and developmental stage specific [14, 15], making findings
from studies using whole blood as a surrogate tissue for spermatozoa difficult to interpret [16].
Despite these caveats, epidemiological evidence suggests that factors such as advanced
paternal age, obesity, diabetes and smoking have the potential to negatively impact the devel-
opment and physiology of a man’s offspring [17–19]. Such associations could be mediated by
alterations to the father’s spermatozoa (Fig 1A), although other possibilities include changes in
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the composition of seminal fluid or indirect effects on the mother and, importantly, postnatal
effects such as paternal behaviour. An improved understanding of whether and how acquired
paternal traits can influence offspring physiology has important implications, both scientifi-
cally and in terms of public health policy. This is particularly pertinent for modifiable traits
such as obesity, where timely intervention could reduce any potential negative intergenera-
tional effects.
It will be a long time before studies of DNA methylation in human spermatozoa reach a
comparable magnitude to those currently available on peripheral blood. Therefore, it is of
interest to identify CpG sites where DNA methylation levels covary between the two tissues,
that is, sites at which blood methylation is predictive of sperm methylation, even if the absolute
level of methylation is different. The extent to which these sites overlap with those identified in
blood as associated with environmental stimuli or acquired phenotypes will provide new
insight into whether the sperm methylome may be similarly responsive. At such CpG sites,
using blood DNA methylation as a proxy for inferring DNA methylation in spermatozoa
might be justified. To our knowledge, the largest study that analysed genome-wide DNA meth-
ylation in an unbiased manner in matched samples of blood and sperm to date included a total
of eight participants [20].
In this study, we analysed genome-wide DNA methylation using the Infinium Methylatio-
nEPIC array in matched samples of human blood and sperm from lean (n = 68; BMI <25kg/
m2) and overweight/obese (n = 22; BMI >26kg/m2; ‘the obesity group’) healthy males of
proven fertility (Fig 1B). We interrogated the extent to which obesity-associated DNA methyl-
ation in blood is reflected in spermatozoa from obese males and identified obesity associated
CpG-sites in sperm and blood. Spermatozoal DNA methylation data was further compared to
that of nearly 6,000 somatic tissue samples available on the Gene Expression Omnibus data
repository [21], allowing us to identify sperm-specific DNA methylation signatures. Together,
Fig 1. Intergenerational epigenetic inheritance via spermatozoa and overview of study groups. (A) Mechanism for how acquired paternal phenotypes could
alter offspring physiology via epigenetic alterations to a man’s spermatozoa. Epidemiological studies suggest that some acquired paternal traits, including obesity
and insulin resistance, are associated with an increased risk of fathering small for gestational age (SGA) offspring [18, 19, 69]. Studies in non-human mammals
suggest that such associations could be mediated by DNA methylation alterations in spermatozoa that induce metabolic reprogramming in the developing foetus
[12]. (B) Overview of study groups. The discovery group included 47 lean males (BMI 19–25 kg/m2) and the replication groups included 21 lean males (BMI 19–25
kg/m2) and 22 overweight/obese males (BMI>26 kg/m2; ‘the obesity group’). Age (years) and BMI (kg/m2) are expressed as mean (SD). SGA: small for gestational
age. SD: standard deviation.
https://doi.org/10.1371/journal.pgen.1009035.g001
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our analyses interrogate the plausibility of spermatozoal DNA methylation as a mechanism for
intergenerational effects of paternal obesity and whether whole blood can be used as a surro-
gate tissue for analyses of DNA methylation when sperm is unavailable. Further, they provide
a unique insight into how spermatozoal DNA methylation compares to DNA methylation in a
wide range of human somatic tissues.
Results
General characterisation of the sperm DNA methylome
We used the Illumina MethylationEPIC array to quantify DNA methylation at> 850,000 CpG
sites across the human genome in matched samples of whole blood and sperm from a discov-
ery group of 47 lean, healthy males of proven fertility. Following pre-processing, normalization
and stringent quality control (see Materials and methods), a total of 704,356 probes were
retained for further analyses. Raw and pre-processed DNA methylation data is available for
download from the Gene Expression Omnibus (GEO) at accession number GSE149318. To
characterize spermatozoal DNA methylation across genomic regions, levels of DNA methyla-
tion were divided into three categories; ‘low’, ‘intermediate’ and ‘high’, corresponding to
median DNA methylation < 20%, 20–80% and> 80% across individuals respectively (Fig 2).
As observed in other tissues and cell types, CpG islands and shores generally show low DNA
methylation in sperm. Conversely, sites mapping to the open sea were characterized by overall
higher DNA methylation (Fig 2A, S1 Table). Gene bodies in spermatozoa displayed overall
high levels of DNA methylation, whilst sparser DNA methylation was seen around transcrip-
tion start sites (TSS) and 5’ untranslated regions (UTRs), as well as the first exons (Fig 2B, S2
Table).
DNA methylation in imprinted regions
Genomic imprinting refers to the phenomenon that genes are epigenetically regulated to be
expressed in a parent-of-origin specific manner [22]. In spermatozoa, imprinted genes should
be either completely unmethylated or fully methylated depending on the gene [22]. Con-
versely, in blood, the parent-of-origin driven allele-specific methylation should result in meth-
ylation values of around 50% for any given imprinted site. DNA methylation levels at CpG
sites annotated to genes listed in the Geneimprint database (http://www.geneimprint.com/
site/genes-by-species) were compared between spermatozoa and whole blood (S1 Fig). In the
case of CpG sites annotated to genes that are known to be imprinted, we observed an enrich-
ment of sites with median DNA methylation of 50% in whole blood, particularly for paternally
imprinted genes (21% sites with 40–60% median DNA methylation vs 3% of sites across the
array-wide background; P< 1.00 × 10−50, Fisher’s exact test), but also for maternally imprinted
genes (11% of sites; P = 9.19 × 10−9). For genes predicted to be imprinted according to the
Geneimprint database, there was a less pronounced enrichment (paternal: 6% of sites;
P = 0.01; maternal: 6% of sites; P = 0.04). No such enrichment was observed for spermatozoal
DNA methylation in any of the four categories (P> 0.05). Because gene annotation on the
methylation array is based only on proximity, this approach includes many CpG sites not actu-
ally located in imprinting control regions (ICRs). Therefore, we also compared DNA methyla-
tion distributions at sites which specifically fall into known human ICRs as reported by
WAMIDEX [23]. This second approach further confirmed an enrichment of probes with
around 50% methylation located in ICRs in blood compared to sperm (S2 Fig). Strikingly, of
the 169 CpG sites that fell into ICRs, the majority show median DNA methylation around 50%
(57% of sites with 40–60% DNA methylation, P< 1.00 × 10−50, Fisher’s exact test vs array-
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wide background). On the other hand, nearly all of the 169 sites were completely unmethylated
in sperm (94% with median DNA methylation < 20%, P< 1.00 × 10−50).
The sperm DNA methylome exhibits a more polarised genome-wide DNA
methylation profile than blood
We compared the overall distribution of DNA methylation levels across the blood and sperm
genomes. Sperm displayed a more polarised methylation profile compared to blood, i.e. that
both low and high median levels of methylation were more commonly seen in sperm (Fig 3A),
with 33% of sites showing median DNA methylation < 20% in sperm vs 27% in blood and
Fig 2. DNA methylation distribution of the human sperm DNA methylome. (A) The percentage of CpG sites that display low (median DNA
methylation< 20%), intermediate (40–60% median DNA methylation) and high (median DNA methylation> 80%) levels of DNA methylation in spermatozoa
are shown according to CpG region. (B) The percentage of CpG sites that display low, intermediate and high levels of DNA methylation in spermatozoa are shown
according to their genomic region. TSS: transcription start site, UTR: untranslated region.
https://doi.org/10.1371/journal.pgen.1009035.g002
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49% of sites with median DNA methylation > 80% in sperm vs 35% in blood. Principal com-
ponent (PC) analysis was performed across the full discovery dataset comprising the 704,356
probes that remained after filtering. The first PC, explaining 51.41% of the variance, clearly
distinguished between sperm and blood, indicating that the tissue of origin was the primary
determinant of differences in DNA methylation profiles (S3 Fig). At the majority of interro-
gated sites, DNA methylation levels differed significantly between sperm and blood
(n = 447,846 sites (64%), P< 9 × 10−8, paired t-test; S3 Table). At 62% of these sites
(n = 277,831 sites), sperm was relatively hypermethylated compared to blood.
A more detailed characterisation of the differences between the sperm and blood DNA
methylomes was performed by comparing DNA methylation levels in sperm and blood across
different genomic regions (Fig 3, S5 and S6 Tables). CpG islands and CpG island shores were
Fig 3. Comparison of DNA methylation levels in human sperm and whole blood. (A) Array-wide comparison of CpG methylation in sperm and blood, showing
that both low (< 20%) and high (> 80%) DNA methylation levels are more commonly seen in sperm. Plotted is the distribution median DNA methylation levels
across all individuals in the discovery group. (B) The percentage of CpG sites that are relatively hyper- and hypomethylated in sperm compared to blood, and CpG
sites where there is no significant difference in DNA methylation between the tissues, are shown according to CpG region. (C) The percentage of CpG sites that are
relatively hyper- and hypomethylated in sperm compared to blood, and CpG sites where there is no significant difference in DNA methylation between the tissues,
are shown according to genomic region. TSS: transcription start site, UTR: untranslated region.
https://doi.org/10.1371/journal.pgen.1009035.g003
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found to be less methylated in sperm compared to blood (7% and 16% lower in sperm respec-
tively, P< 1.0 × 10−50 for both, paired t-test). CpG island shelves and CpG sites in open seas
were relatively hypermethylated in sperm compared to blood (6% and 7% higher in sperm
respectively, P< 1.0 × 10−50 for both) (Fig 3B, S5 Table). Regions upstream of transcriptional
start sites were relatively hypomethylated in sperm compared to blood (2% lower at TSS200
and 0.11 at TSS1500, P< 1.0 × 10−50 for both), as were sites mapping to the 3’UTR (1% lower,
P = 3.81 × 10−5) or first exon (1% lower, P< 1.0 × 10−50). Conversely, other transcribed
regions were hypermethylated in sperm compared to blood, including gene bodies (2% higher,
P< 1.0 × 10−50), 5’UTRs (1% higher, P = 1.3.61× 10−32), and exon boundaries (2% higher,
P = 2.80 × 10−22; Fig 3C, S6 Table). We replicated these differences in the lean replication
(n = 21 lean males) and obesity groups (n = 22 overweight/obese males) (S1 Text, S4 Fig and
S3 Table).
Sperm has a unique DNA methylation profile enriched in pathways
relating to transcriptional regulation
The Gene Expression Omnibus (GEO) is a publicly available data repository that contains
DNA methylation data from a range of human tissue samples, most of which have been ana-
lysed using the Illumina Infinium HumanMethylation450 BeadChip (450K array) [21]. In
order to investigate how the DNA methylation profile of spermatozoa compares to that of
somatic tissues, DNA methylation data from 371 sperm samples (90 from our discovery, repli-
cation and obesity groups combined and 281 samples from GEO) was compared to that of
5,917 somatic tissue samples from male donors available on GEO (see S7 and S8 Tables for
details on tissue samples). Restricting analysis to CpG sites covered by both the EPIC and
450K arrays (n = 452,626 sites) we used linear regression to identify sperm-specific DNA
methylation signals across the 6,288 samples. After Bonferroni correction, a total of 133,125
genome-wide significant CpG sites (29%) were identified as differentially methylated between
sperm and somatic tissues (S9 Table). At 18% of these sites (n = 109,290 sites) sperm was char-
acterized by higher methylation levels than somatic tissues. This is in contrast to the paired
analysis with blood and likely due to the nearly exclusive coverage of CpG islands on the 450K
array. Gene Ontology (GO) enrichment analysis [24] revealed 272 GO terms amongst hyper-
methylated CpG sites (S10 Table). The main two categories of enriched pathways related to
regulation of gene transcription (37 pathways) and neurological traits and functions (67 path-
ways). The latter is possibly driven by the relatively large proportion of brain and neuronal
samples amongst the somatic tissues (16%). Of the 37 GO terms enriched amongst hypo-
methylated CpG sites, 8 (22%) related to sensory perception, particularly smell (S11 Table).
We repeated the same analysis removing unsorted tissues and tumours as well as cell lines
(1,046 samples) and replicated virtually the same results.
Covariation of DNA methylation between sperm and blood is limited and
most likely explained by genetic variation
We next explored whether, despite the blood and sperm DNA methylomes being highly dis-
tinct, there were CpG sites where the levels of DNA methylation covaried between the tissues.
We used minimum variability criteria for sites to be tested to avoid correlations driven by indi-
vidual outliers, similar to those used by Hannon and colleagues [15]: we selected sites for
which the middle 80% of samples had a DNA methylation range� 5% in both blood and
sperm. This restricted our analyses to 155,269 variable sites. At 1,513 of these (~1%), DNA
methylation levels were significantly correlated between the two tissues (P< 9 × 10−8, Pear-
son’s product moment correlation; Fig 4A, S12 Table).
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Fig 4. Covariation of DNA methylation between blood and sperm. (A) The observed correlation of DNA
methylation levels in sperm and blood (histogram) is plotted against the estimated null distribution (red density
curve). A small percentage of sites display highly correlated DNA methylation levels (r> 0.8), and the observed
distribution is overall slightly shifted to the right compared to the null distribution. (B) cg02024240 (chr5:159669974)
shows a strong DNA methylation correlation between blood and sperm and a trimodal methylation pattern suggestive
of a genetically driven effect (r> 0.99, P = 4.68 × 10−48). (C) cg25317025 (chr18:47019823) is one of 30 sites showing a
PLOS GENETICS DNA methylation covariation in human whole blood and sperm
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Given the observation of several bi- and trimodal patterns of DNA methylation amongst
highly correlated sites (Fig 4B), we applied two separate methods (see Materials & methods),
to identify which of the 1,513 significantly correlated CpG sites exhibit these patterns. The
majority of correlated CpG sites showed a bimodal distribution (kmeans method: 1,140 (75%);
gaphunter: 885 (58%) in blood, 898 (59%) in sperm) and a substantial number of sites were
characterized by a trimodal distribution (kmeans method: 205 (14%); gaphunter: 355 (23%) in
blood, 367 in sperm (24%)). These strong bi- and trimodal distributions are suggestive of a
strong genetic influence on DNA methylation or the measurement thereof. Such effects could
for example arise from SNPs in the CpG sites themselves (where the methylation value would
represent a genotype call rather than methylation measurement), from very strong mQTLs
leading to three distinct levels of methylation for the three genotypes at the QTL, or possibly
because a SNP in the probe sequence is biasing the measurement of DNA methylation. Probes
with the highest correlation coefficients tended to show clear trimodal patterns (Fig 4B), while
a third of bimodally distributed probes appear to be driven by single outliers (kmeans method:
365 (32%); gaphunter: 369 (42%) in blood, 381 (42%) in sperm; S5 Fig). A subset of correlated
sites (30 i.e. 2%) displayed a negative correlation between DNA methylation in sperm and
blood (Fig 4C) and at a small number of sites distinct trimodal methylation patterns are pres-
ent in only one of the two tissues (Fig 4D).
We cross-checked all correlated sites for known SNPs in the probe sequence using the
dbSNP Human Build 151 database [25]. Nearly all probes (1,507; > 99%) were found to have
known SNPs in the probe sequence, > 90% of which are in the CpG site itself (Fig 5). This
would indicate that DNA methylation readouts at these sites are most likely measuring genetic
variation rather than epigenetic state. Only a small subset (n = 6) of the CpG sites that were sig-
nificantly correlated had no known SNPs in their probe sequence. Some of these nevertheless
displayed bi- and trimodal patterns of DNA methylation suggestive of a genetically driven
effect and could potentially constitute strong mQTLs (Fig 4E).
Secondly, we overlapped our correlated CpG sites with a list of recently reported correlated
regions of systemic interindividual variation (CorSIV) in DNA methylation [26]. Only 0.2% of
non-correlated variable probes are contained in CorSIVs—in line with the low overall genomic
prevalence of these regions (0.1% of the human genome). Strikingly, we observe a 10-fold
enrichment of this within the correlated sites (2.2%, P = 8.85 × 10−25, Fisher’s exact test). The
observations from the sperm data suggest that for sites exhibiting bi- and trimodal methylation
patterns there is a likely genetic origin (of either a SNP in the CpG site or strong methylation
QTL effects). Therefore, this enrichment conflicts with the hypothesis that for at least these
sites, the origin of cross-tissue covariation is developmentally established stable epialleles [27].
Finally, using cis DNA methylation QTL data from whole blood published by McClay and col-
leagues [28] we found that 232 (30%) of the correlated sites also present on the 450K array had
previously been identified as mQTLs in whole blood, representing a significant enrichment
over the 16% observed across all variable probes (P = 1.66 × 10−33, Fisher’s exact test). Correla-
tions largely replicated in the two replication groups. (S1 Text, S12 Table) and non-replicating
sites were generally driven by outliers in the discovery group (examples shown in S6 Fig).
negative correlation between blood and sperm (r = -0.89, P = 5.14 × 10−17). (D) Some probes display striking
differences in variability between the two tissues: cg20673407 (chr10:31040939) is characterized by a distinct trimodal
pattern in whole blood while showing less overall variability in sperm (r = 0.82, P = 1.45 × 10−12). (E) Only 6 of the
significantly correlated probes have no known SNPs anywhere in the probe sequence. cg02486009 (chr15: 22428395) is
one of these (r = 0.96, P = 1.90 × 10−27). Nonetheless it shows a bimodal DNA methylation pattern in both tissues,
suggestive of a genetically driven effect.
https://doi.org/10.1371/journal.pgen.1009035.g004
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Limited evidence for converging associations between DNA methylation
and obesity from whole blood and sperm
We next investigated whether obesity was associated with DNA methylation in sperm or
blood. At the 697,384 sites that passed quality control in the combined replication group,
including lean and obese males, we used linear regression of DNA methylation on obesity sta-
tus, controlling for estimated blood cell types in the blood dataset. No probes passed array-
wide significance (P< 9 × 10−8) in blood or sperm (S13 Table). Given our small sample size,
we leveraged published data from a larger EWAS of BMI in whole blood [1]; see Materials and
methods). First, we tested whether the 187 replicated array-wide significant probes
(P< 1.0 × 10−7) reported by Wahl and colleagues, which were also present in our data, were
enriched in lower-ranked P values in our data, and secondly, we compared effect sizes at these
187 probes between our samples and the published data. To make both analyses comparable
we treated BMI as a continuous measure for these comparisons—as Wahl and colleagues had
done in the original epigenome-wide association study. Both analyses confirmed enrichments
of the reported associations in blood but not sperm: lower-ranked P values were enriched in
blood (P< 1.3 × 10−23, Wilcoxon rank sum test) but not sperm (P = 0.06, Fig 6A) and simi-
larly, the reported effects at the 187 probes were correlated significantly with effects observed
in our blood data (ρ = 0.72, P< 1.0 × 10−50, Spearman’s rank correlation, Fig 6B) but not in
sperm (ρ = 0.13, P = 0.11, Fig 6C). This indicates that the associations identified by Wahl and
colleagues do not generalize to sperm. Next, to maximise power within our own sample, we
ran a linear mixed effects model across the discovery and replication datasets, using the
692,265 probes that survived quality control in both datasets. DNA methylation was regressed
onto tissue (blood versus sperm), age, batch and obesity status, while controlling for interindi-
vidual variation with a random effect (S13 Table). This analysis found that methylation at one
Fig 5. Positions of known SNPs in probe sequences of correlated probes. 1,507 of the 1,513 significantly correlated
probes have known SNPs in their probe sequence. The vast majority of these (> 90%) map to the CpG site itself.
https://doi.org/10.1371/journal.pgen.1009035.g005
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Fig 6. Obesity associated DNA methylation patterns in whole blood and sperm. Out of all replicated CpG sites
reported to be associated with BMI by Wahl et al. (P< 1.0 × 10−7), 187 were also present in our replication group of
lean and obese men. We regressed BMI onto DNA methylation in each tissue, controlling for estimated blood cell
types in the blood analysis to match the analysis used by Wahl and colleagues. (A) Lower-ranked P values were found
to be enriched amongst these 187 sites in blood (P< 1.3 × 10−23, Fisher’s exact test) but not sperm (P = 0.06). (B)
PLOS GENETICS DNA methylation covariation in human whole blood and sperm
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CpG site, cg19357369 (chr4:2429884), was significantly increased in obese men in sperm and
blood (2% higher DNA methylation, P = 8.95 × 10−8, Fig 6D). Finally, we compared our results
with those of a previous study, which identified associations between paternal weight and off-
spring DNA methylation in a sample of 429 father-mother-child triads [29]. Out of the nine
probes at which Noor and colleagues found an association between cord blood DNA methyla-
tion and paternal periconceptional BMI, only one showed a nominally significant association
in consistent effect direction in the sperm obesity EWAS (P = 0.028, DNA methylation differ-
ence = 6%) and the combined mixed effects model in blood and sperm (P = 0.01, DNA methyl-
ation difference = 4%). While the association in our data is weak and the probability of
observing a false positive association across 18 tests (nine probes, two models) is almost 40%,
the fact that the association of this probe is observed across both models and in consistent
effect direction is encouraging and warrants further investigation.
No association between obesity or metabolic traits and epigenetic age
acceleration
Because obesity is associated with a higher risk for multiple age-related diseases, it has been
suggested that this might occur via inducing accelerated cellular ageing [30]. Several studies
used DNA methylation age acceleration—the discrepancy between a person’s chronological
age and their age predicted based on DNA methylation profiles—to investigate an association
between obesity and accelerated ageing [30, 31], leading to inconsistent results. However, a
recent meta-analysis [32] showed a small positive association between DNA methylation age
acceleration in whole blood and BMI across seven studies. To test this association in our data,
we derived three different estimates of DNA methylation age. In line with previous reports, we
confirmed that the DNA methylation age estimator developed by Horvath [4] correlated sig-
nificantly with chronological age when derived in whole blood (r = 0.74, P = 2.55 × 10−9, Pear-
son’s product moment correlation), but not in sperm (r = 0.26, P = 0.07, S7 Fig). This is likely
because the Horvath DNA methylation was developed using only 45 samples of semen in a
total of 7,844 samples (0.6%) of different tissue samples, including 4,180 blood-derived sam-
ples (53%) [4]. However, age could more accurately be predicted from sperm DNA methyla-
tion using the model recently developed by Jenkins and colleagues [33], which was specifically
trained on sperm samples (r = 0.68, P = 1.78 × 10−7, S7 Fig). The PhenoAge estimator [34], a
biomarker of biological rather than chronological ageing, which has been shown to predict
age-related traits and morbidity, was significantly correlated with chronological age in blood
(r = 0.73, P = 5.18 × 10−9) but not sperm (r = 0.26, P = 0.08, S7 Fig).
We regressed DNA methylation age acceleration from the three models in blood and sperm
onto five weight-related or metabolic traits: BMI, obesity (being in the obese/overweight
group), waist circumference, insulin resistance (HOMA-IR) and fasting insulin. None of these
25 linear regressions identified significant associations between accelerated DNA methylation
age and the five traits (P> 0.05 for all tests, S8 Fig, S14 Table).
Effect sizes at the 187 probes were significantly correlated between our blood data and the summary statistics published
by Wahl and colleagues (ρ = 0.72, P< 1.0 × 10−50, Spearman’s rank correlation). (C) No such correlation was observed
for our sperm data (ρ = 0.13, P = 0.11). (D) In a linear mixed effects model across the discovery and replication
datasets, DNA methylation was regressed onto tissue (blood versus sperm), age, batch and obesity status, while
controlling for interindividual variation. This analysis identified significant hypermethylation at one CpG site,
cg19357369 (chr4:2429884), in obese compared to lean men across the two tissues (2% higher DNA methylation,
P = 8.95 × 10−8).
https://doi.org/10.1371/journal.pgen.1009035.g006
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Obesity does not significantly influence the covariation of DNA
methylation between sperm and blood
To investigate whether the covariation of DNA methylation was significantly altered in obe-
sity, we ran an interaction model that regressed DNA methylation in blood onto DNA methyl-
ation in sperm, obesity status and their interaction effect, while covarying for experimental
batch and age (see Materials and methods). We identified 98 CpG sites with a statistically sig-
nificant interaction between obesity and the association of blood and sperm DNA methylation
(P< 9 × 10−8). Interactions at the vast majority of these CpG sites (96) were driven by individ-
ual outliers in the obesity group; the remaining two sites appear to be driven by outliers in the
lean group and a batch effect (S9 Fig). We therefore conclude that we were not able to identify
credible altered DNA methylation covariation patterns between blood and sperm that may
have arisen as part of a gene-environment interaction.
Discussion
In this study, we characterized the sperm methylome in relation to blood and other somatic
tissues, investigated covariation between DNA methylation in sperm and whole blood and
analysed DNA methylation patterns associated with obesity. We conclude that the DNA meth-
ylation profiles of sperm and blood are highly distinct, and that there is little evidence of DNA
methylation covariation between the two tissues, beyond genetic and technical effects.
In line with previous, smaller-scale studies, we showed that the sperm DNA methylome is
highly polarised compared to that of blood, with both low (DNA methylation < 20%) and
high (DNA methylation > 80%) levels of DNA methylation more frequently observed in
sperm than in blood [20]. In contrast to previous research, however, we found that the sperm
DNA methylome is overall slightly hypermethylated compared to that of blood [20, 35, 36].
This finding is potentially influenced by the fact that the previous generations of DNA methyl-
ation arrays (the 450K array) included a higher proportion of CpG islands, which are relatively
hypomethylated in spermatozoa [20, 37].
We identified significant differences in DNA methylation levels at the majority of assayed
CpG sites when comparing whole blood to sperm. Additionally, in our comparison of the sper-
matozoal DNA methylome to that of almost 6,000 somatic tissue samples, we showed that
gene ontology terms enriched amongst hypermethylated CpG sites in sperm pointed repeat-
edly to transcriptional regulation. This is an intriguing finding considering that recent research
has shown that high overall levels of transcription during spermatogenesis facilitate transcrip-
tion-coupled DNA repair mechanisms through so-called “transcriptional scanning” [38].
Given that transcriptional regulation is an essential process for all cell-types, it is striking to
observe sperm-specific DNA methylation patterns enriched in these processes. It could suggest
that DNA methylation is involved in widespread transcriptional downregulation as cells prog-
ress from an active transcriptional stage during spermatogenesis to a more transcriptionally
repressed stage in mature sperm.
About 1% of variable sites in whole blood and sperm showed a significant correlation of
DNA methylation between the whole blood and sperm. This is slightly lower than what has
been reported for comparisons of DNA methylation between whole brain and peripheral tis-
sues [39]. Furthermore, at the vast majority of correlated CpG sites, the correlation appeared
to be driven by underlying genetic variation resulting in characteristic bi- and trimodally clus-
tered distributions of DNA methylation. In most of these cases, known SNPs were identified
in the CpG site itself or in the single base extension. This finding is further supported by the
observed enrichment of mQTLs [28] and CorSIVs [26] amongst correlated sites. Thus, whilst
we lack specific genotyping information on individual participants in this study, our findings
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strongly suggest genetic variation as the underlying cause of DNA methylation covariation
between blood and sperm. This is despite the fact that we employed stringent filtering of
probes in close proximity to SNPs from previously published lists [37, 40, 41], which suggests a
need to update existing reference lists.
We also identified a small number of CpG sites where DNA methylation was negatively
correlated between blood and sperm, and sites where DNA methylation exhibited a trimodal
distribution pattern in one tissue only. It would be of interest to investigate further whether
pathophysiological traits are associated with an increase in DNA methylation in one tissue and
a decrease in the other. In particular, whether germ cell or leukocyte specific transcription fac-
tors are responsible for the discordant yet correlated DNA methylation distribution patterns
across blood and sperm.
The small number of sites (6 out of 1,513) where no obvious genetic driver of methylation
variability was identified are likely too few to be of value in studies where blood is needed as a
surrogate tissue for sperm. The results of this study are generally in line with similar studies of
DNA methylation covariation, such as between whole blood and various brain regions [15],
albeit more extreme. They emphasize the importance of using disease-relevant tissues in epige-
nomic investigations. These findings do not however, generally preclude the use of readily
accessible tissues such as blood or saliva for identifying DNA methylation biomarkers of con-
ditions relating to germ cell function, such as subfertility. For example, if a robust DNA meth-
ylation profile of subfertility is identified in blood, this could be a helpful test in fertility
evaluations without necessarily reflecting the epigenetic profile of spermatozoa.
This study identified one CpG site, cg19357369, as hypermethylated in sperm and blood
from obese versus lean males. The finding should be interpreted with caution as it requires
replication and just passed the array-wide multiple testing threshold—which was not corrected
for the different aspects pertaining to sperm DNA methylation across the study (comparison
with blood, correlation with blood, interaction, single-tissue EWAS, multi-tissue EWAS). The
effect size was also comparatively small (2% higher DNA methylation in the obese group).
cg19357369 is found upstream of the lncRNA RP11-503N18, which has yet to be characterised
in terms of biological function [42]. However, previous research has shown that DNA methyla-
tion at cg19357369 is significantly altered during human fetal brain development [43].
Although cg19357369 has previously been identified as differentially methylated in hepatic tis-
sue from obese compared to lean males [42], it has not previously been identified in EWASs of
obesity or BMI when only blood samples have been analysed. If shown to be replicable, it
could point towards the possibility of an obesity associated signature of spermatozoa.
Overall, we found that differentially methylated CpG sites associated with BMI in a large-
scale EWAS in blood were not evident in sperm. Therefore, our current understanding of epi-
genetic associations of weight-associated phenotypes, which stems almost exclusively from
studies of whole blood, is unlikely to give us functional insights into how these may be passed
to offspring. Furthermore, in contrast to some previous reports, we did not identify any signifi-
cant associations between obesity or metabolic traits and accelerated epigenetic ageing in
blood or sperm.
There are limitations to our study. First, it constitutes an observational, cross-sectional
study and we are therefore unable to comment on the causality behind observed associations
between obesity and spermatozoal DNA methylation. The limited sample size of the obesity
group (n = 22) reduced our ability to detect any modest association between obesity and DNA
methylation covariation between sperm and whole blood. The obesity group included a pro-
portion of overweight males (BMI 25–30 kg/m2), which potentially diluted our results. Fur-
ther, while we used the most comprehensive DNA methylation array currently available, the
MethylationEPIC array is still biased towards certain parts of the genome (most notably
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enhancer regions, RefSeq genes and CpG islands) and does not give a complete picture of
genome-wide CpG methylation [44]. Lastly, although we were able to speculate as to the effects
of genetic variants in CpG sites influencing our results, given trimodal methylation patterns
and the presence of known SNPs in the CpG site, we did not have the actual genetic sequence
of our subjects to verify this directly.
The study has several strengths. It constitutes the largest unbiased analysis of DNA methyla-
tion in matched human sperm and blood samples performed to date, and is one of the largest
studies of spermatozoal DNA methylation in healthy males of proven fertility. In contrast to
several previous analyses of DNA methylation in human spermatozoa [45–47], our study
includes a replication group, increasing the robustness of our findings. Crucially, our analyses
include the use of large existing datasets; blood-sperm correlated CpG sites were interrogated
for overlap with previously identified mQTLs in whole blood [28], as well as with a list of
recently reported CorSIVs [26]. We used findings from one of the largest studies of obesity-
associated DNA methylation in blood performed to date [1] to analyse whether obesity-associ-
ated DNA methylation observed in blood was also reflected in spermatozoa. Lastly, we used
recently developed DNA methylation analysis pipelines for large DNA methylation datasets
[48] to identify sperm-specific DNA methylation signatures by comparing spermatozoal DNA
methylation data to that of almost 6,000 somatic tissue samples available on GEO [21].
Together, these analyses allowed us to interrogate the spermatozoal DNA methylome in novel
ways and provide highly suggestive evidence for why spermatozoal DNA methylation as a
mechanism for intergenerational effects of obesity in humans is unlikely.
Recent research supports our conclusion that paternal BMI is unlikely to influence his off-
spring via DNA methylation. For example, a large-scale meta-analysis comprising almost
7,000 offspring found little evidence of an association between prenatal paternal BMI and off-
spring blood DNA methylation at birth or in childhood [49]. More research is warranted to
help understand whether other epigenetic mechanisms, such as small RNA species, may be
more influential in mediating effects of paternal obesity on offspring health, such as has been
shown in non-human mammals [50, 51]. It would also be of interest to investigate the associa-
tion between paternal traits other than BMI, such as smoking and ageing, and spermatozoal
DNA methylation in an unbiased, genome-wide manner [52].
Our data suggests that compared with a wide range of somatic tissues, human sperm dis-
plays a unique DNA methylation profile, particularly in pathways relating to transcriptional
regulation. We show that DNA methylation levels in human blood and sperm are only corre-
lated at a minority of CpG sites and that at such sites, DNA methylation covariation is most
likely due to genetic effects. The use of peripheral blood as a surrogate tissue for human sper-
matozoa is therefore inadvisable. Obesity does not generally influence spermatozoal DNA
methylation, nor the covariation of DNA methylation between blood and sperm. Further, obe-
sity-associated CpG sites identified in peripheral blood do not show enrichment in spermato-
zoa from obese individuals. Taken together, our findings suggest that if there are inter- and
transgenerational effects of human obesity, they are unlikely to be mediated by changes in
spermatozoal DNA methylation.
Materials and methods
Samples
Whole blood and semen samples were collected from participants recruited from University
College London Hospital (UCLH) May 2016—March 2019. Participants were phenotyped
with regards to BMI, waist circumference, systolic and diastolic blood pressure, blood lipids,
fasting insulin and glucose levels and C-reactive protein (CRP). Two groups of participants
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were included; lean (BMI<25kg/m2) and overweight/obese (BMI >26kg/m2). Phenotypic
information about participants is detailed in S4 Table, which shows clear differences in meta-
bolic variables between these groups. To determine BMI, participants were weighed wearing
only light clothing and their height was measured by a trained researcher during the same
research clinic visit as when their blood samples were taken, and within two weeks of provid-
ing a sperm sample. Participants provided information about their medical history and lifestyle
via questionnaires, and were excluded if they suffered from significant medical conditions,
took regular medications or smoked cigarettes. All participants were of proven fertility.
Peripheral blood samples were centrifuged at 3000g for 15 minutes within one hour of vene-
puncture and the buffy coat was used for DNA extraction.
Semen samples were processed within one hour of sample production as per UCLH proto-
col and analysed for sperm concentration, motility and average progressive velocity using the
Sperminator/Computer Assisted Sperm Analysis system (Pro-Creative Diagnostics, Stafford-
shire, UK). Semen sample parameters are detailed in S15 Table. All semen samples were within
normal parameters according to World Health Organization criteria [53]. Samples underwent
gradient centrifugation (45 and 90% PureSperm medium; PureSperm 100, Nidacon Laborato-
ries, PS100-100) to select for motile spermatozoa as described elsewhere [54]. The processed
samples were microscopically assessed for cell purity such that only samples with no visible
cells other than spermatozoa were included in downstream analyses.
Ethics approval and consent to participate
Ethical approval for the study was granted from the South East Coast—Surrey Research Ethics
Committee on 28 September 2015 (REC reference number 15/LO/1437, IRAS project ID
164459). The study was also registered with the University College London Hospital Joint
Research Office (Project ID 15/0548). All participants provided written, informed consent.
DNA extraction
DNA from 200 μL buffy coat derived from whole blood was extracted using Qiagen QIAamp
DNA Blood Mini Kit (Qiagen, Cat No. 51104) according to manufacturer’s instructions [55].
DNA from the pellet of motile spermatozoa was extracted using a standard phenol-chloroform
extraction method as described previously [56]. DNA extracted from whole blood and sperm
was quality controlled using a Qubit 3.0 Fluorometer (Life Technologies, Cat No. Q33216).
DNA was stored in -80˚C prior to bisulphite conversion.
Methylomic profiling
DNA (500 ng) from each sample was sodium bisulphite-treated using the Zymo EZ 96 DNA
methylation kit (Zymo Research, Cat No. D5004) according to the manufacturer’s instruc-
tions. DNA methylation was quantified using the Illumina Infinium MethylationEPIC Bead-
Chip [44] using an Illumina iScan System [57]. Samples were assigned a unique code for
identification and randomized with regards to group and other variables to avoid batch effects,
and processed in two batches. The Illumina Genome Studio software was used to extract the
raw signal intensities of each probe (without background correction or normalization). Raw
DNA methylation data is available for download from GEO (accession number GSE102538).
Data pre-processing
Data analysis was performed in R version 3.6.2. DNA methylation data was processed and ana-
lysed using the wateRmelon package in R [58]. An initial outlier analysis was performed using
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the outlyx() function in wateRmelon based on 1) the interquartile range of the first principal
component and 2) the pcout algorithm [59] detecting outliers in high dimensional datasets,
leading to the removal of 1 individual from the discovery group, 2 individuals from the obesity
group and 3 Individuals from the lean replication group. The 59 non-CpG SNP probes on the
array were used to confirm that the genotypes at these 59 probes were identical for the
matched samples.
Prior to data analysis, 9,779 probes were removed from the discovery data because more
than 5% samples displayed a detection P value> 0.05. Furthermore, 3,337 probes were
removed because of having a bead count< 3. Probes containing SNPs in close proximity to
the CpG site (within 10 base pairs) as well as potentially cross-reactive probes were filtered
using annotated lists from three sources [37, 40, 41], leading to the removal of 149,105 CpG
sites. The final discovery data set comprised 704,356 CpG sites. Data was normalized in the R
package wateRmelon using the dasen() function as previously described [58]. The lean and
obese replication groups were processed together experimentally and therefore jointly pre-pro-
cessed and normalised using the same parameters as for the discovery dataset. A total of
697,442 probes survived quality control and filtering in the replication data. DNA methylation
was analysed as beta values, which is the ratio of methylated probe intensity over the overall
intensity and approximately equal to the percentage of methylated sites (% DNA methylation).
Data analysis
Characterization of DNA methylation in sperm. CpG sites were assigned to chromo-
somes, locations, genes, and genomic regions using the Illumina manifest for the EPIC array
(hg19 reference). CpG sites were classified as having either ‘high’ (median DNA
methylation > 80%) or ‘low’ (median DNA methylation < 20%) DNA methylation. Enrich-
ments of each genomic or CpG region amongst ‘high’ and ‘low’ methylation sites were calcu-
lated against the background (sites showing 20–80% median DNA methylation) using a
Fisher’s exact test.
Annotation of imprinted genes/ imprinting control regions. CpG sites were annotated
to imprinted genes using the Illumina manifest for the EPIC array and the list of imprinted
genes published in the Geneimprint database (http://www.geneimprint.com/site/genes-by-
species). Enrichments of intermediate methylation levels were calculated as Fisher’s exact tests
of number of sites with 40–60% median DNA methylation levels annotated to imprinted genes
against the array-wide background. For known human imprinting control regions (ICR) we
used the locations reported by WAMIDEX [23], these were lifted to hg19 and overlapped with
CpG locations using the R package GenomicRanges [60]. Enrichments for intermediately
methylated (40–60% median DNA methylation) and unmethylated (median DNA
methylation < 20%) sites were calculated as Fisher’s exact tests.
DNA methylation differences between blood and sperm. Sites characterized by differ-
ences in DNA methylation between whole blood and sperm were identified by a paired t-test
of matched samples. Comparison of the difference in DNA methylation levels between sperm
and blood at different genomic regions was performed by calculating a paired t-test of median
DNA methylation in sperm vs blood across all sites annotated to a specific genomic or CpG
region.
GEO analysis. DNA methylation data for 6,288 samples was downloaded from the Gene
Expression Omnibus (GEO) including 281 sperm samples and 5,971 somatic tissue samples
from male donors, profiled using the 450K or EPIC arrays. Statistical analyses were performed
using the bigmelon package in R and statistical tests were performed using limma [48, 61]. In
the comparison of DNA methylation between sperm and tissue samples from males on GEO, a
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linear model was fitted using the lmFit() function from the limma R package [61] across the
452,626 CpG sites that are present on both the EPIC and 450K arrays. The model regressed
DNA methylation onto tissue (sperm vs not sperm) and included age and array type (450K or
EPIC) as covariates. For sperm samples from GEO which lacked recorded age, the estimated
age based on Jenkin’s model was used instead. The data was not normalised because global
large-scale differences between somatic tissues and sperm were expected, and because the high
number of different types of samples included was expected to ameliorate issues around tech-
nical noise. We performed principal components analysis (PCA) of all samples from the 93
GEO datasets included in this analysis, to check for global effects of dataset or tissue of origin
(S10 Fig). The gene ontology (GO) pathway analysis was performed using the gometh() func-
tion from the missMethyl R package [62], which removes ambiguously assigned probes from
the enrichment analysis.
Correlation between whole blood and sperm DNA methylation. In order to minimise
the effect single outliers would have on the correlation analysis, a subset of ‘variable’ probes
was identified by calculating the DNA methylation difference between the 10th and 90th per-
centile across all samples, and selecting sites where this was at least 5% in both whole blood
and sperm (n = 155,269 sites). This approach is similar to the one described by Hannon and
colleagues previously [15]. Correlated CpG sites between sperm and blood were identified by
Pearson’s correlation test across all variable probes. In order to establish the matching null dis-
tribution, samples were permuted 100 times and correlations between DNA methylation in
whole blood and sperm were recalculated across all variable sites. The density curve of these
simulated correlations was added to the histograms of the empirical correlation coefficients to
represent the null distribution (Fig 4). To investigate the clustering of DNA methylation pat-
terns at significantly correlated CpG sites we used two separate methods: 1) kmeans method: a
two dimensional outlier test was used by adapting the rosnerTest() function from the EnvStats
R package [63] to exclude unimodal distributions. Next, k means clustering was applied for 2
and 3 clusters as implemented in the function pamk() of the R package cluster [64]. This func-
tion determines the best fitting number of clusters (two or three—corresponding to bi- and
tri-modal methylation distributions). We manually checked and, if necessary, reassigned clus-
ters which exhibited low between-cluster to within-cluster variance ratios (ratio < 2). 2)
gaphunter: we applied the gaphunter() function from the Bioconductor package minfi [65] to
blood and sperm DNA methylation values, identifying multimodal DNA methylation patterns
in each tissue. This algorithm looks for consistent differences of> 5% DNA methylation, but
only works on one-dimensional data, so had to be applied to each tissue separately.
Annotation of SNPs and genetic enrichments. To annotate SNPs to their location within
probe sequences we used the Illumina EPIC hg38 manifest and dbSNP database build 151 in
the SNPlocs.Hsapiens.dbSNP151.GRCh38 R package. SNPs were mapped to probes using the
GenomicRanges R package [60] and the distance to the CpG site of the closest SNP in the
probe sequence was calculated for each of the 1,513 probes with significant correlations
between sperm and blood. We downloaded the locations of the 9,226 correlated regions of sys-
temic interindividual variation (CORSIV) in DNA methylation recently published by Gunase-
kara and colleagues [26]. These were overlapped with the locations of CpG sites using the hg38
manifest and the GenomicRanges R packages. Finally, we downloaded the list of cis methyla-
tion QTLs (mQTLs) in blood reported by McClay and colleagues [28]. These were identified
using the 450K array, which meant we had to restrict this annotation to probes present on
both the EPIC and 450K array. Enrichments for CORSIVs and mQTLs were calculated by
Fisher’s exact test against the background of non-correlated variable probes.
Obesity and DNA methylation in blood and sperm. Two models were used to investi-
gate the association between obesity and DNA methylation in sperm and blood. First, DNA
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methylation was regressed onto obesity status in the combined replication group, in blood and
sperm separately. This analysis was controlled for estimated blood cell counts in blood. Sec-
ondly, a mixed effects model was run across both the discovery and replication groups using
the lmer() function from the lme4 package in R [66], regressing DNA methylation onto tissue
(blood versus sperm), age, batch and obesity status, while controlling for interindividual varia-
tion with a random effect:
lmerðMethylation�Tissueþ Ageþ Batchþ Obesityþ ð1jIDÞÞ
Given our small sample size—especially in the obese group—we downloaded summary sta-
tistics from an EWAS of BMI in whole blood [1]. 187 of the replicated array-wide significant
probes (P< 1.0 × 10−7) reported by Wahl and colleagues were also present in our dataset. To
make our data comparable we treated BMI as a continuous measure for these comparisons,
regressing BMI onto obesity status and controlling for estimated blood cell proportions in the
blood analysis. We tested for an enrichment of lower ranked P values amongst the 187 previ-
ously reported probes in our analysis using a Wilcoxon rank sum test. Secondly, we looked at
correlations of effect sizes reported by Wahl and colleagues and observed in our data across
the 187 probes using Spearman’s rank correlation to allow for study-specific biases.
DNA methylation age estimates and age acceleration associations. DNA methylation
age was estimated on the discovery sample from both blood and sperm DNA methylation
using Horvath’s DNA methylation age estimator [4] as implemented in the watermelon R
package. We additionally estimated DNA methylation age from sperm using the method
described by Jenkins and colleagues [33] and from blood and sperm using the PhenoAge [34]
estimator by uploading raw DNA methylation data to the DNA Methylation Age Calculator
website (http://dnamage.genetics.ucla.edu). We additionally downloaded DNA methylation
age acceleration scores for Horvath’s estimator and PhenoAge from the website, using the
residual based method, which accounts for estimated blood cell composition in the linear
regression. We generated DNA methylation age acceleration scores for Jenkin’s estimator by
taking the residuals of the regression of Jenkin’s DNA methylation age estimator onto chrono-
logical age.
DNA methylation age acceleration based on the three estimators was regressed onto five
weight-related or metabolic traits across all samples from the discovery and replication groups:
BMI, obesity (where all members of the obese/overweight group were defined as obese), waist
circumference, insulin resistance (measured by the Homeostatic Model Assessment of Insulin
Resistance (HOMA-IR)) and fasting insulin levels.
Interaction between obesity, tissue and DNA methylation. To detect and interaction
between obesity and the association between blood and sperm DNA methylation we ran linear
model regressing DNA methylation in blood onto DNA methylation in sperm, obesity status
and their interaction effect, while covarying for experimental batch and age:
lmðMethylationBlood�Methylationsperm�Obesityþ Ageþ BatchÞ
Cell-type composition. As whole blood represents a heterogenous tissue where the com-
position of leukocytes can introduce bias in the interpretation of DNA methylation analysis
findings, blood cell type counts of monocytes, granulocytes, NK-cells, B cells, CD8+-T-cells,
and CD4+-T-cells were estimated from the DNA methylation data using the method described
by Houseman [67]. These estimates were included in all analyses that were run on the blood
dataset alone as described above.
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Multiple testing correction. For agnostic analyses across the whole EPIC array (including
those restricted to variable probes), the threshold P< 9 × 10−8 was applied as reported in
recently published statistical guidelines for the EPIC array [68]. For the GEO analysis only the
set of probes present on both the 450K and EPIC array were used. We applied Bonferroni cor-
rection across these 452,626 sites.
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using linear regression. This analysis was conducted across all 452,626 sites that are present on
both the 450K and EPIC array. Summary statistics are reported for all sites. IlmnID = Illumina
CpG identifier, chr = chromosome, location = position on chromosome in hg19 reference, P = P
value for difference between sperm and somatic cell DNA methylation, P_Bonferroni = Bonfer-
roni-adjusted P value, effect = DNAmethylation difference (beta)–negative values indicate lower
DNA methylation in sperm compared to somatic tissues.
(ZIP)
S10 Table. Significantly enriched Gene ontology terms amongst CpG sites identified to be
hypermethylated in sperm compared to somatic tissues. GO analysis identified 272 path-
ways enriched amongst hypermethylated sites. Of note, 37 of these (14%) related to transcrip-
tional regulation, while 67 (25%) were related to brain and neurological categories. GO
ID = Gene Ontology identifier, N = number of genes in the GO term, DE = number of genes that
were differentially methylated, P.DE = P value for over-representation of the GO term, ONTOL-
OGY: BP = biological process, CC = cellular component, MF =molecular function.
(ZIP)
S11 Table. Significantly enriched Gene ontology terms amongst CpG sites identified to be
hypomethylated in sperm compared to somatic tissues. GO analysis identified 37 pathways
enriched amongst hypomethylated sites. Eight of these pathways were related to sensory per-
ception, specifically smell. GO ID = Gene Ontology identifier, N = number of genes in the GO
term, DE = number of genes that were differentially methylated, P.DE = P value for over-repre-
sentation of the GO term, ONTOLOGY: BP = biological process, CC = cellular component,
MF =molecular function.
(ZIP)
S12 Table. Summary statistics for correlation of DNA methylation between whole blood
and sperm. We used a Pearson’s correlation test to identify CpG sites where DNA methylation
was significantly correlated between whole blood and sperm This analysis was restricted to the
155,269 sites that showed met minimum variability criteria in both tissues (range of middle
80%> 5%). Summary statistics are reported for all sites in the discovery dataset. Summary sta-
tistics from the replication groups are reported for the sites that also passed quality control in
our replication dataset. IlmnID = Illumina CpG identifier, chr = chromosome, location = posi-
tion on chromosome in hg19 reference, P = p-value in the discovery data, r = correlation coeffi-
cient in the discovery data, P_rep = p-value in the lean replication group, r_lean = correlation
coefficient in the lean replication group, P_ob = p-value in the obese replication group,
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r_ob = correlation coefficient in the obese replication group.
(ZIP)
S13 Table. Summary statistics for the association between DNA methylation and obesity
in whole blood and sperm. We regressed DNA methylation onto obesity status in our com-
bined replication dataset, separately in whole blood and sperm, controlling for estimated
blood cell type proportions in the blood analysis. We furthermore used a linear mixed effects
model across the combined discovery and replication datasets, regressing DNA methylation
onto obesity status, tissue type and batch while controlling for interindividual variation. Sum-
mary statistics for both analyses are reported—the LME results are restricted to sites available
in both the discovery and replication datasets. IlmnID = Illumina CpG identifier, chr = chromo-
some, location = position on chromosome in hg19 reference, P_blood = p-value in blood analysis,
effect_blood = effect size in whole blood, P_sperm = p-value in sperm analysis, effect_sperm =
effect size in sperm, P_mix = p-value in the mixed effects model, effect_mix = effect size in the
mixed effects model. All effect sized are reported using the lean men as reference group.
(ZIP)
S14 Table. Associations between DNA methylation age acceleration and weight-related or
metabolic traits. DNA methylation age acceleration based on three different estimators was
separately regressed onto five weight-related or metabolic traits: BMI, obesity (being in the
obese/overweight group), waist circumference, insulin resistance (HOMA-IR) and fasting
insulin. None of the 25 associations were significant (P > 0.05 for all tests).
(DOCX)
S15 Table. Semen sample parameters for the discovery and replication groups (the lean
replication group and the obesity group). Semen sample parameters were measured using
the Computer-Assisted Sperm Analysis (CASA)/Sperminator software (Pro-Creative Diagnos-
tics, Staffordshire, UK). V = volume, C = concentration, SD = Standard Deviation, WHO =
World Health Organization. Percentage A-D sperm refer to the proportion of spermatozoa in
different motility grades where A = most motile and D = least motile. Reference ranges derived
from [53].
(DOCX)
S1 Fig. DNA methylation at CpG sites annotated to imprinted genes is enriched in inter-
mediate levels of DNA methylation in blood, but not sperm. DNA methylation annotated to
known imprinted genes (Geneimprint database; http://www.geneimprint.com), showed a
characteristic enrichment in sites with DNA methylation around 50% (+/- 10%) in whole
blood—particularly, those genes known to be paternally imprinted (P< 1.00 × 10−50, Fisher’s
exact test), but also for maternally imprinted genes (P = 9.19 × 10−9) and a less pronounced
enrichment in genes predicted to be imprinted paternally (P = 0.01) or maternally (P = 0.04).
No such enrichment was observed in sperm (P> 0.05 for all four tests).
(TIFF)
S2 Fig. Imprinting control regions are around 50% methylated in whole blood, while being
nearly completely unmethylated in sperm. Nearly all of the 169 CpG sites that are located in
known imprinting control regions (ICRs) display intermediate DNA methylation levels in
blood (57% of sites with median DNA methylation between 40 and 60%; P< 1.00 × 10−50,
Fisher’s exact test). Simultaneously, they appear to be completely unmethylated in sperm (94%
of sites with median DNA methylation < 20%, P< 1.00 × 10−50).
(TIFF)
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S3 Fig. Load of DNA methylation on first 20 principal components (PCs) in whole blood
and sperm. The first PC, which explained 51.41% of the total variance, clearly distinguishes
between blood and sperm, making tissue/cell type the single biggest factor contributing to vari-
ation in DNA methylation across our samples.
(TIFF)
S4 Fig. Differences observed between whole blood and sperm DNA methylation replicated
across two replication datasets. The effect sizes at the 441,764 significant probes from discov-
ery, which were also present in the replication datasets, were highly correlated with those
observed in the replication groups (lean group: r = 98%, P< 1.0 × 10−50; obese group: r = 0.99,
P< 1.0 × 10−50).
(TIFF)
S5 Fig. 365 of the 1,513 significantly correlated sites were driven by single outliers. Shown
is DNA methylation in whole blood and sperm from the discovery and replication datasets at
(A) cg02474032 (chr16:87678659), (B) cg25554892 (chrX:70434406), and (C) cg07636088
(chr13: 31734946). We observed higher measured DNA methylation in the individual outlier
at less than 2% of these 365 sites.
(TIFF)
S6 Fig. Correlations which did not replicate were driven small numbers of individual outli-
ers in the discovery data. Of the 1,250 correlated probes also present in the replication data
173 (13%) show no evidence of correlation in the replication datasets (r< 0.3 in both datasets)
(A) The majority of these sites (127 sites; 76%) were characterized by a single outlier in the dis-
covery data, without any outliers in the replication datasets. One example is found at
cg06819230 (chr16:67567158). (B) cg25253080 (chr10:14795564) represents the only incidence
where a set of 5 outliers did not replicate in either replication group. (C) The biggest set of out-
liers which did not replicate contained 6 individuals, with no outliers in the replication data
and was found at cg27045994 (chr8:284126). (D) The only trimodal distribution which did not
replicate was observed at cg17118288 (chr1:218563763).
(TIFF)
S7 Fig. DNA methylation age prediction in whole blood and sperm. As reported previously,
the DNA methylation age predictor by Horvath was significantly correlated with chronological
age in whole blood but not in sperm. However, chronological age could be more accurately
predicted from DNA methylation in sperm using the predictor more recently developed by
Jenkins and colleagues. Like the Horvath methylation age estimator, the PhenoAge estimator
showed stronger correlations with chronological age in blood than in sperm. Note that the
lean and obese/overweight replication groups were combined into one “replication” group for
these analyses.
(TIFF)
S8 Fig. No significant associations between DNA methylation age acceleration and weight-
related or metabolic traits. Scatter plots of DNA methylation age acceleration based on three
different estimators and four weight-related or metabolic traits (BMI, waist circumference,
Homa-IR and fasting insulin) are shown in whole blood and sperm. Linear regressions were
performed for each of these 20 comparisons: No significant associations were identified. Note
that all discovery and replication groups were combined for this analysis.
(TIFF)
S9 Fig. Statistically significant interaction effects were driven by outliers in either the
obese or lean groups. The majority of significant interactions between sperm and blood DNA
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methylation and obesity were driven by single or very few outliers in the obesity group. (A) At
cg23132872 (chr2:191882300), the correlation in obese individuals is driven by a single outlier.
(B) At cg22086461 (chr8:77343728) the correlation in obese individuals is driven by two outli-
ers. (C) At cg17166874 (chr7:155381422) the correlation in lean men is driven by four outliers
in the discovery data and methylation at this site is also characterized by substantial batch
effects. (D) At cg19778375 (chr12:297831) there appears to be a batch effect between the dis-
covery and replication datasets that contributes to an observed correlation in the lean men
from the discovery cohort, which is not present in the replication datasets.
(TIFF)
S10 Fig. PCA plots for all samples downloaded from GEO. DNA methylation profiles were
downloaded from 93 separate datasets on GEO. From a combined PCA, the loads on the first
four principal components for each sample are shown here, coloured by dataset of origin and
tissue (legend only shown for tissues). While individual datasets often only contain a single tis-
sue of origin and therefore batch and tissue effects may overlap and there are clearly study spe-
cific effects, we also see similarities between samples of the same tissue type across datasets.
(TIFF)
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